Quantcast
Channel: ACTC.OB investor blog
Browsing latest articles
Browse All 10 View Live

ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China

The Company issued the following announcement this morning. ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China Chinese Patent to Cover Fundamental Methods for Producing Retinal...

View Article



Reuters interviews ACT’s Dr. Robert Lanza: Embryonic stem cells still “gold...

Following are excerpts from a Reuters story that ran on March 31, 2011; it includes quotes from an interview with ACT’s Chief Scientific Officer, Dr. Robert Lanza. The original article may be found...

View Article

ACT Announces UCLA Institutional Review Board (IRB) Approval of its Phase 1/2...

The company issued the following press release today. UCLA’s Jules Stein Eye Institute to be a Site for Phase 1/2 Trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-related Macular Dystrophy...

View Article

Advanced Cell Technology Praises Federal Appeals Court Ruling Allowing for...

The company issued the following press release today. Advanced Cell Technology Praises Federal Appeals Court Ruling Allowing for Continued Federal Funding of Embryonic Stem Cell Research Ruling Could...

View Article

ACT Interim Chairman and CEO Gary Rabin to Present at World Stem Cells &...

The company issued the following release today. ACT Interim Chairman and CEO Gary Rabin to Present at World Stem Cells & Regenerative Medicine Congress in London Mr. Rabin Will Discuss Two Upcoming...

View Article


Advanced Cell Technology Announces 2011 First Quarter Results

The company issued the following release today. Advanced Cell Technology Announces 2011 First Quarter Results MARLBOROUGH, Mass. — May 9, 2011 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a...

View Article

ACT Announces Oregon Health & Science University As Clinical Trial Site for...

The company issued the following release today. ACT Announces Oregon Health & Science University As Clinical Trial Site for its Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular...

View Article

ACT and Roslin Cells Announce Collaboration for Storage and Distribution of...

The company issued the following announcement this morning. ACT and Roslin Cells Announce Collaboration for Storage and Distribution of Embryonic Stem Cells Using ACT’s Blastomere Technology Embryonic...

View Article


Scientific Luminary Dr. Robert Langer Joins ACT’s Board of Directors

World-renowned scientist and youngest member ever elected to all three U.S. National Academies; Also named One of the 100 Most Important People in America by Time Magazine and CNN MARLBOROUGH, Mass. —...

View Article


ACT Publishes First Report of Embryonic Stem Cell (ESC)-Derived Cells...

Study in The Lancet Shows No Safety Concerns and Improved Vision in Patients with Macular Degeneration MARLBOROUGH, Mass. — Jan. 23, 2012 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader...

View Article
Browsing latest articles
Browse All 10 View Live




Latest Images